Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Simonin

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Blood|September 19, 2025
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohortQuentin Neven, Chloé Arfeuille, Aurélie Caye-Eude, et al.
Blood Cancer Journal|January 27, 2022
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteinsThomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, et al.
The Journal of Experimental Medicine|August 20, 2014
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangementAgata Cieslak, Sandrine Le Noir, Amélie Trinquand, et al.
Blood|June 7, 2024
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patientsMathieu Simonin, Loïc Vasseur, Etienne Lengliné, et al.
Haematologica|July 11, 2024
Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximabMarie Emilie Dourthe, Anne Auperin, Charlotte Rigaud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trialLaurence Brugières, Nathalie Cozic, Roch Houot, et al.
Hemasphere|April 22, 2026
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adultsMathieu Simonin, Mathieu Viennot, Stéphanie Haouy, et al.
Nature|March 21, 2024
Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiencyEmmanuel Martin, Sarah Winter, Cécile Garcin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2024
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelinesCédric Rossi, Guillaume Manson, Amira Marouf, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Blood|September 19, 2025
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohortQuentin Neven, Chloé Arfeuille, Aurélie Caye-Eude, et al.
Blood Cancer Journal|January 27, 2022
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteinsThomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, et al.
The Journal of Experimental Medicine|August 20, 2014
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangementAgata Cieslak, Sandrine Le Noir, Amélie Trinquand, et al.
Blood|June 7, 2024
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patientsMathieu Simonin, Loïc Vasseur, Etienne Lengliné, et al.
Haematologica|July 11, 2024
Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximabMarie Emilie Dourthe, Anne Auperin, Charlotte Rigaud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trialLaurence Brugières, Nathalie Cozic, Roch Houot, et al.
Hemasphere|April 22, 2026
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adultsMathieu Simonin, Mathieu Viennot, Stéphanie Haouy, et al.
Nature|March 21, 2024
Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiencyEmmanuel Martin, Sarah Winter, Cécile Garcin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2024
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelinesCédric Rossi, Guillaume Manson, Amira Marouf, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Pageof 5